Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ExoCoBio logo — ExoCoBio improves the quality of life with exosome-based tec...

ExoCoBio

ExoCoBio improves the quality of life with exosome-based technology Our Exosomes Your Future

Founded 2017 Korea South Korea South 29 employees Series C Total: $47.30M Biotechnology, Health Care +2

General Information

Company Name ExoCoBio
Founded Year 2017
Location Korea South Korea South +1
Founders / Decision Makers
Team member Team member
Employees 29
Industries Biotechnology, Health Care, Pharmaceutical +1
Funding Stage Series C
Social

Get notified when ExoCoBio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ExoCoBio

ExoCoBio, established in 2017, is a pioneering company in the Biotechnology sector, focusing on developing exosome-based solutions. Their slogan, "ExoCoBio improves the quality of life with exosome-based technology," underscores their commitment to enhancing human health and wellness.

Positioned at the intersection of Health Care and Wellness Beauty, ExoCoBio differentiates itself as the first and leading company globally in EXOsome COsmeceuticals & BIOpharmaceuticals. Headquartered in Korea South, the company has made significant strides in the Pharmaceutical industry by pioneering innovative applications for exosomes.

In its most recent financing round, ExoCoBio secured a $9.30 million Series C investment on 01 August 2020. This funding featured contributions from notable investors including Focus Assets Management, K2 Investment Partners, Knotus, Dt& Investment, SBI Investment Korea, and G.N. Tech Venture, highlighting strong market confidence in its technological prospects.

Taxonomy: Exosome Technology, Cosmeceuticals, Biopharmaceuticals, Stem Cell-Derived Exosomes, Therapeutics Development, Innovative Cosmetics, Quality of Life Improvement, Exosome-Based Products, Personal Care Innovations, Biotech Research, Regenerative Medicine, Advanced Skincare Solutions

Services & Products

R&D in Exosome Technology
Development of Regenerative Therapeutics
Immuno-Oncology Solutions
Biopharmaceutical Product Development
Innovation in Bio Ingredients

Target Customers

Healthcare Providers Pharmaceutical Companies Cosmetic Industry Biotech Companies Dermatology Clinics

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 6
Investor Investor Investor Investor Investor
•••• •••• 		01 Aug 2020
Series B •••••• 8
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		01 Sep 2018
Series A •••••• 2
Investor Investor
01 May 2017

ExoCoBio Alternatives & Competitors

ExoCoBio vs
Theoria Science
Theoria Science

Specializing in exosome research, pioneering cancer diagnostics and treatments, and excelling in ins...

Series Unknown
Biotechnology, Care Economy
Compare ExoCoBio vs Theoria Science
ExoCoBio vs
ABIO MATERIALS
ABIO MATERIALS Korea South

Pioneering biotech innovations for a brighter future

Seed
10 employees
Biotechnology
Compare ExoCoBio vs ABIO MATERIALS
ExoCoBio vs
Rosetta Exosome Co., Ltd.
Rosetta Exosome Co., Ltd. Korea South

The Exosome Company, reinventing the future with exosome.

Series A
6 employees
Health Care, Medical Devices
Compare ExoCoBio vs Rosetta Exosome Co., Ltd.

FAQ About ExoCoBio

ExoCoBio improves the quality of life with exosome-based technology Our Exosomes Your Future
ExoCoBio was founded in 2017.
ExoCoBio is headquartered in Korea South.
ExoCoBio operates in the following industries: Biotechnology, Health Care, Pharmaceutical, Wellness Beauty.
ExoCoBio has approximately 29 employees.
ExoCoBio has completed 3 funding rounds, raising a total of $47.30M. The latest funding stage is Series C.
ExoCoBio offers: R&D in Exosome Technology, Development of Regenerative Therapeutics, Immuno-Oncology Solutions, Biopharmaceutical Product Development, Innovation in Bio Ingredients.
Top alternatives and competitors to ExoCoBio include Theoria Science, ABIO MATERIALS, Rosetta Exosome Co., Ltd., Aopia Biosciences, VivaZome Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ExoCoBio and Theoria Science are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ExoCoBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy